← All stocks

Kairos Pharma, LTD.

KAPA Net buying

CIK 0001962011 #5350 in the set updated 21 Sep 2026

Bought (120 mo)

$9.83K

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$9.83K

+$9.83K against sales at will

By person

7 insiders · 3 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Yu John S

CEO and Chairman

$5.76K (1)

—

+$5.76K

230,105

0.9710%

$365.87K

+982.1%

Samuelson Doug

Chief Financial Officer

$3.75K (1)

—

+$3.75K

293,039

1.24%

$465.93K

+112.6%

Murali Ramachandran

VP of Research and Development

$318.00 (1)

—

+$318.00

299,529

1.26%

$476.25K

+125.8%

Bhowmick Neil

Chief Scientific Officer

—

1,311,739

5.54%

$2.09M

+16.5%

Bae Hyun W.

Director

—

73,370

0.3096%

$116.66K

+65.7%

Singhvi Rahul

Director

—

49,204

0.2076%

$78.23K

+63.4%

Keyoung Hansoo Michael

Director

—

29,084

0.1227%

$46.24K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 13

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 787,192

History held since 21 Nov 2024